Stay updated on UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Sign up to get notified when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.

Latest updates to the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2025-03-13' to '2025-03-25'.SummaryDifference1.0%
- Check37 days agoChange DetectedThe date on the webpage has been updated from February 11, 2025, to March 13, 2025.SummaryDifference0.7%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check65 days agoChange DetectedThe page has updated the study title to 'Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies' and added a new date of '2025-02-11', while removing the previous trial title and date of 'Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies' and '2024-05-30'.SummaryDifference4%
Stay in the know with updates to UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.